(Panel 3a shows the schematic drawing of the individual grades of hypoechoic SH for GS alone. (Panel 3a shows the schematic drawing of the individual grades.

Slides:

Advertisements

Similar presentations

Patient with ankle affection Individual US findings

Advertisements

Ko-Jen Li, Song-Chou Hsieh Journal of Medical Ultrasound

Figure 2, supplementary online file

Mid-sagittal US images in an 11-year-old boy with the wrist in (A) neutral position showing a bulging MC recess (measured from the surface of the capitate.

European League Against Rheumatism/American College of Rheumatology classification criteria probability of having idiopathic inflammatory myopathies (IIMs)

(A) EULAR response based on DAS28 (ESR, otherwise CRP) and (B) Boolean remission, at 6 months in patients treated with abatacept as a first-line biologic.

Flow chart of the steps in the EMEUNET Peer Review Mentoring Program.

Time to discontinuation of TNF-inhibitors (TNF-i) and non-TNF-inhibitors (non-TNFi), non-adjusted (non-adj) and adjusted (adj) for propensity score survival.

Kaplan-Meier survival plots for survival without: (A) progression to RA according to the number of joints with significant synovitis defined by GS≥ grade.

Percentage of patients achieving EULAR response

Baseline scores and corresponding changes to week 96 of the RAPID-axSpA trial for all CZP-treated patients included in the imaging substudy for: (A) SPARCC.

Prevalence of any pathological finding for inflammation (intratendinous or peritendinous inflammatory signal, bone marrow oedema at the painful sites)

Clinical and patient-reported outcomes for patients randomised to CZP 200 mg Q2W and CZP 400 mg Q4W to week 96. Clinical and patient-reported outcomes.

Changes in clinical disease activity over 24 months on a continuous scale in SWEFOT trial participants randomised to triple therapy or anti-TNF with available.

The patient profiles presented to rheumatologists in the discrete choice experiment (DCE). aCCP, anti-cyclic citrullinated peptide; DAS28, 28-joint Disease.

Frequency of patients in flare at each time point over 3 months

Schematic presentation of enrichment through linkages of clinical Rheumatology register data to other national data sources within each of the five Nordic.

ACR response rates at 24 weeks in patients treated with PBO, IXEQ4W or IXEQ2W alone or in combination with cDMARDs or MTX. The proportions of patients.

Signal intensity is dependent on scaling

Three different reconstructions after one single mDixon sequence of

P75NTR and disease severity (A) in persistent oligoarticular (n=29), extended oligoarticular (n=16) and polyarticular (n=13) patients p75NTR mRNA expression.

MTX-PG concentrations and hepatotoxicity.

Efficacy outcomes in patients aged ≥65 years versus younger patients: ACR outcomes at (A) week 12 and (B) week 24. Efficacy outcomes in patients aged ≥65.

Spectrum of ultrasound grey scale on the dorsal aspects of the wrists ((a) to (d)), MCPs ((e) to (h)), PIPs ((i) to (l)) and MTPs ((m) to (p)): grade 0.

Ratings of core domains stratified by stakeholder group in the second Delphi round. Ratings of core domains stratified by stakeholder group in the second.

CAIA is attenuated in Nrdc – / – mice.

XY plots with regression lines (red) showing the relationship between average (left panel) and peak (right panel) tissue stress at all bone sites for dual-energy.

Foot maps showing the patterns of average tissue stress, peak tissue stress, urate deposition in gout and bone erosion in gout. Foot maps showing the patterns.

Different treatment strategies in rheumatoid arthritis in relation to radiographic progression (A) number of swollen joints (B) and fatigue severity over.

DAS28-CRP cut-off values corresponding to the DAS28-ESR cut-off values for remission, LDA and HDA, average of three statistical approaches. DAS28-CRP cut-off.

Probability plots JSN score at baseline (A), 10 years (B) and progression (C) for the different age groups (darkest dots: group

EULAR-defined characteristics describing arthralgia at risk for RA

Treatment strategy. Treatment strategy. For every patient, changes of treatment were analysed per change, for up to five subsequent therapeutic changes.

The association between alcohol consumption and the severity of MRI-detected inflammation in hand and foot joints of (A) patients with RA and (B) asymptomatic.

Representative ultrasound images of patients with SLE

Clinical expertise of GPs and rheumatologists in differentiating patients with arthralgia. Clinical expertise of GPs and rheumatologists in differentiating.

Relative impact of the different levels of education on the physical and mental components of SF-12 across the different chronic disorders. Relative impact.

Examples of MRI at presentation with clinically suspect arthralgia (CSA) (top panel) and at IA development (bottom panel), showing joints (A) from no inflammation.

Graphical display for QUADAS-2 results.

Improvement in FACIT-F fatigue score according to ACR20 response status (ACR, American College of Rheumatology; DMARD, disease-modifying antirheumatic.

Radiographic endpoints: (A) change from baseline in SHS at Week 52 and Week 104*†; (B) probability plots of change from baseline in SHS at Week 52 and.

Relative treatment effects concerning efficacy endpoints in patients with inadequate response to methotrexate for triple therapy versus TNFi–methotrexate.

SRMs at 3 and 6 months for the final ultrasound inflammation score (USRA9) bilaterally and previously proposed scores (A) GSUS in the early RA cohort,

Results from the second Delphi step showing the percentage of rated domains that the experts agreed on as domains for the annual systemic assessment of.

Rates of ACR50 response and prespecified MTX-related adverse events in patients in the (A) CONCERTO study over 26 weeks and (B) MUSICA study over 24 weeks. ACR50, American.

Distribution of swelling and tenderness in joints with or without x-ray progression. Distribution of swelling and tenderness in joints with or without.

ACR20/50/70 response rates at week 24 (TP1 per-protocol set).

MRI, STIR sequence of sacroiliac joints (SIJs): minimal localised signal increase on both sides of the upper part of the left SIJ (arrows), which does.

Imaging methods of photography, MSUS, X-rays and FOI in evaluating a patient with PsA. Imaging methods of photography, MSUS, X-rays and FOI in evaluating.

Ultrasonographic characteristics and synovitis pattern of patients with inflammatory bowel disease (IBD) with onset of peripheral arthritis under tumour.

Ultrasound examination and conventional radiography of the second proximal interphalangeal joint at baseline (2009) and follow-up (2013). Ultrasound examination.

Satisfaction with control of RA

MRI in individuals with symptomatic knee osteoarthritis illustrating the structural abnormalities that discriminate symptomatic knee osteoarthritis best.

“Tennis Leg”. “Tennis Leg”. Serial Longitudinal images of the calf: (1) There is a well localised hypoechoic collection (C) interposed between the medial.

Schematic depiction of categories of inflammation in 350 small joints during progression from clinically suspect arthralgiato inflammatory arthritis. Schematic.

Classification tree with the selected characteristics.

February 1998 (age 14 years and 8 months).

(A) NKG2A and (B) NKG2C expression on NK cells in subjects with AS and HCs. The upper figure represents % of NK positive cells; the lower figure represents.

Network graph illustrating the relation between the assessed structural abnormalities on different locations within the knee joint in the total NEO study.

Changes over time in DAS 28 (A), SLEDAI (B), glucocorticoid dose (C) and EULAR response (D) in patients with rhupus treated by anti-TNF-α. Box plot (median,

(A) Detailed comparison of the prevalence of single pathological lesions in both heel and knee in patients with SpA and non-SpA patients, as assessed by.

Nail photographs and MRI scans of a patient with psoriatic arthritis.

Depiction of bone marrow oedema using different techniques

Improvement in BASDAI score in patients with normal or elevated CRP at baseline through week 156. *p

Ultrasonographic picture of second metatarsophalangeal joint with synovitis (panel A) and without synovitis (panel B). a, metatarsal head; b, base of.

Intra-articular Nrdc gene silencing with siRNA attenuates CAIA

The final ultrasound inflammation score (USRA9) for rheumatoid arthritis. The final ultrasound inflammation score (USRA9) for rheumatoid arthritis. (Included.

Kaplan-Meier failure curves with development of RA stratified by depression exposure. Kaplan-Meier failure curves with development of RA stratified by.

Antibody treatment ameliorates inflammation in experimental arthritis.

Baker’s cyst (photomontage).

Presentation transcript:

(Panel 3a shows the schematic drawing of the individual grades of hypoechoic SH for GS alone. (Panel 3a shows the schematic drawing of the individual grades of hypoechoic SH for GS alone. For each grade is also shown the corresponding GS image. (1) None=Grade 0: no SH independently of the presence of effusion; (2) minimal=Grade 1: SH with or without effusion up to level of horizontal line connecting bone surfaces M and P; (3) moderate=Grade 2: SH with or without effusion extending beyond joint line but with upper surface convex (curved downwards) or hypertrophy extending beyond joint line but with upper surface flat; (4) severe=Grade 3: SH with or without effusion extending beyond joint line but with upper surface flat or convex (curved downwards). Panel 2b shows the schematic drawing of the individual grades for Doppler activity. For each grade is also shown the corresponding ultrasound image. (1) None=Grade 0: no Doppler activity; (2) minimal=Grade 1: up to three single Doppler spots or up to one confluent spot and two single spots or up to two confluent spots; (3) moderate=Grade 2: greater than Grade 1 but <50% Doppler signals in the total GS background; (4) severe=Grade 3: greater than Grade 2 (>50% of the background GS). Panel 2c shows the EULAR-OMERACT score for PDUS synovitis combining grey-scale SH and PD signal. Normal joint=Grade 0: no grey-scale-detected SH and no PD signal (within the synovium); minimal synovitis=Grade 1: Grade 1 SH and ≤Grade 1 PD signal; moderate synovitis=Grade 2: Grade 2 SH and ≤Grade 2 PD signal or Grade 1 SH and a Grade 2 PD signal; severe synovitis=Grade 3: Grade 3 SH and ≤Grade 3 PD signal or Grade 1 or 2 synovial hypertrophy and a Grade 3 PD signal. fx1, connective tissue; EULAR, European League Against Rheumatism; GS, grey-scale; fx2, hypertrophy; fx3, joint line; fx4, loose intra-articular connective tissue; M, metacarpal head; P, proximal phalangeal bone; OMERACT, Outcome Measures in Rheumatology; PD, power Doppler; SH, synovial hypertrophy. Maria-Antonietta D’Agostino et al. RMD Open 2017;3:e000428 Copyright © BMJ Publishing Group & EULAR. All rights reserved.